SCRN1 and prostate cancer: Two of those, PAP and galectin-3, have already been suggested as potential biomarkers for prostate cancer. Secernin-1 2D-DIGE analysis also revealed that secernin-1 shows significantly lower abundance in recurrent prostate cancer tumors compared to prostate cancer tumors without biochemical relapse.